Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators

Cardiology Journal

Volumn 17, Issue 3, 2010, Pages 267-273

  Sherazi, Saadia ^a   Zareba, Wojciech ^b   Daubert, James P ^c   Mcnitt, Scott ^b   Shah, Abrar H ^b   Aktas, Mehmet K ^b   Block, Robert C ^b  

^a UNITY HEALTH SYSTEM   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gender and racial disparities; Implantable cardioverter defibrillator; Physician's knowledge

Indexed keywords

ADULT; ARTICLE; CARDIOLOGIST; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FEMALE; GENERAL PRACTITIONER; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFORMATION DISSEMINATION; ISCHEMIC HEART DISEASE; MALE; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; TREATMENT INDICATION; UNITED STATES; AGE; AGED; ANCESTRY GROUP; ATTITUDE TO HEALTH; CARDIOLOGY; CARDIOVERSION; CLINICAL PRACTICE; DEVICES; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; UTILIZATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CARDIOLOGY; CONTINENTAL POPULATION GROUPS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW YORK; ODDS RATIO; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 77953341911     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics - 2007 Update. A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation, 2007; 115: e69-e171.
2. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States: 1989 to 1999. Circulation, 2001; 104: 2158-2163.
3. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation, 1998; 98: 2334-2351.
4. Lombardi G, Gallagher J, Gennis P. Outcome of out-of-hospital cardiac arrest in New York City: The Pre-Hospital Arrest Survival Evaluation (PHASE) Study. JAMA, 1994; 271: 678-683.
5. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med, 1996; 335: 1933-1940.
6. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med, 1999; 341: 1882-1890.
7. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002; 346: 877-883.
8. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005; 352: 225-237.
9. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near--fatal ventricular arrhythmias. N Engl J Med, 1997; 337: 1576-1583.
10. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology//American Heart Association Task Force on Practice Guidelines. Circulation, 2008; 117: e350-e408.
11. Hernandez AF, Fonarow GC, Liang L et al. Sex and racial differences in the use of implantable cardioverter-defibrillator among patients with heart failure. JAMA, 2007; 298: 1525-1532.
12. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex difference in the use of implantable cardioverter defibrillators for primary and secondary prevention of sudden cardiac death. JAMA, 2007; 298: 1517-1524.
13. Redberg RF. Disparities in use of implantable cardioverter--defibrillatores: Moving beyond process measures to outcomes data. JAMA, 2007; 298: 1564-1566.
14. Stross JK, Harlan WR. The dissemination of new medical information. JAMA, 1979; 241: 2622-2624.
15. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med, 1994; 331: 1136-1142.
16. Zareba W, Moss AJ, Hall J et al. Clinical course and Implantable Cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol, 2005; 16: 1265-1270.
17. Russo AM, Poole JE, Mark DB et al. Primary prevention with defibrillator therapy in women: Results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol, 2008; 19: 720-724.
18. Vorobiof G, Goldenberg I, Moss A, Zareba W, McNitt S. Effectiveness of implantable cardioverter defibrillator in Blacks versus Whites. Am J Cardiol, 2006; 98: 1383-1386.
19. Russo AM, Hafley GE, Lee KL et al. Racial differences in outcome in the Multicenter Unsustained Tachycardia Trial (MUSTT): A comparison of Whites versus Blacks. Circulation, 2003; 108: 67-72
20. Mitchell JE, Hellkamp AS, Mark DB et al. Outcome in African American and Other Minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J, 2008; 155: 501-506.
21. Sanders GD, Hlatky MA, Every NR et al. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Ann Intern Med, 2001; 135: 870-883.
22. Zwanziger J, Hall WJ, Dick AW et al. The cost-effectiveness of implantable cardioverter-defibrillators. Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol, 2006; 47: 2310-2318.
23. Huang DT, Sesselberg HW, McNitt S et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: A MADIT II Substudy. J Cardiovasc Electrophysiol, 2007; 18: 833-838.
24. Myerburg RJ. Implantable cardioverter defibrillators after myocardial infarction. N Engl J Med, 2008; 359: 2245-2253.
25. Irvine J, Dorian P, Baker B et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J, 2002; 144: 282-289.
26. Mark DB, Anstrom KJ, Sun JL et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med, 2008; 359: 999-1008.